Trial intelligence / Profile preview

Topical pregabalin for peripheral neuropathic pain in diabetic neuropathy

IRCT20181208041882N15Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of pregabalin in diabetic neuropathy (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Intensity of neuropathic pain. Started Jun 2019; status: completed.

02

Drugs

pregabalin
03

Conditions

diabetic neuropathy

Beyond the preview

Go deeper on IRCT20181208041882N15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20181208041882N15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call